Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Randomized Controlled Trial by Steinhubl, Steven R, Berger, Peter B, Mann III, J. Tift, Fry, Edward T. A, DeLago, Augustin, Wilmer, Charles, Topol, Eric J, for the CREDO Investigators

Get full text

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial) by Lincoff, A.Michael, Bittl, John A, Kleiman, Neal S, Sarembock, Ian J, Jackman, J.Daniel, Mehta, Sameer, Tannenbaum, Mark A, Niederman, Alan L, Bachinsky, William B, Tift-Mann, J, Parker, H.Graham, Kereiakes, Dean J, Harrington, Robert A, Feit, Frederick, Maierson, Elizabeth S, Chew, Derek P, Topol, Eric J

Get full text

Letter to the Editor by Mann III, J. Tift

Get full text

Unprotected left main disease managed with drug-eluting stents: Long-term outcome of 100 patients with increased surgical risk by Wood, Frances O., Saylors, Elizabeth K., Schneider, Joel E., Jobe, R. Lee, Mann III, J. Tift

Get full text

A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention: Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study by MOLITERNO, David J, HERMILLER, James B, LEVINE, Glenn N, MANN, Tift III, NAIR, Ravi N, STINE, Ronald A, YACUBOV, Steven J, TCHENG, James E, KEREIAKES, Dean J, YOW, Eric, APPLEGATE, Robert J, BRADEN, Gregory A, DIPPEL, Eric J, FURMAN, Mark I, GRINES, Cindy L, KLEIMAN, Neal S

Get full text

Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial by Blankenship, James C, Tasissa, Gudaye, O’Shea, J.Conor, Iliadis, Elias A, Bachour, Fouad A, Cohen, David J, Lui, Henry K, Mann, Tift, Cohen, Eric, Tcheng, James E

Get full text